Steroid-induced osteoporosis: How can it be avoided?

Nephrology Dialysis Transplantation

Volumn 18, Issue 5, 2003, Pages 861-864

  Jehle, Peter M ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Bisphosphonates; Calcium; HRT; Osteoporosis; Steroids; Vitamin D

Indexed keywords

ALENDRONIC ACID; ALFACALCIDOL; BISPHOSPHONIC ACID DERIVATIVE; CALCITONIN; CALCITRIOL; CALCIUM; CONJUGATED ESTROGEN; ESTROGEN DERIVATIVE; ETIDRONIC ACID; FLUORIDE; GLUCOCORTICOID; ORAL CONTRACEPTIVE AGENT; PHOSPHATE; PLACEBO; PREDNISONE; RISEDRONIC ACID; SODIUM; STEROID; TESTOSTERONE DERIVATIVE; VITAMIN D;

AMENORRHEA; CALCIUM BALANCE; CALCIUM INTAKE; CLINICAL TRIAL; CORTICOSTEROID INDUCED OSTEOPOROSIS; EDITORIAL; FLUOROSIS; HORMONE SUBSTITUTION; HUMAN; KINESIOTHERAPY; LONG TERM CARE; MEDICAL EDUCATION; MEDICAL SPECIALIST; NUTRITIONAL STATUS; OSTEOLYSIS; PHOSPHATE INTAKE; PHYSICIAN; PRIORITY JOURNAL; RISK ASSESSMENT; SODIUM INTAKE; TREATMENT INDICATION; VITAMIN SUPPLEMENTATION;

BONE REMODELING; CALCITONIN; CALCIUM, DIETARY; DIPHOSPHONATES; ESTROGEN REPLACEMENT THERAPY; FEMALE; FLUORIDES; HUMANS; MALE; OSTEOPOROSIS; STEROIDS; VITAMIN D;

EID: 0038702141     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/gfg067     Document Type: Editorial

References (23)

1. Weinstein RS, Jilka RL, Parfitt AM, Manolagas SC. Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone. J Clin Invest 1998; 102: 274-282
2. Van Staa TP, Leufkens HG, Abenhaim L, Zhang B, Cooper C. Use of oral corticosteroids and risk of fractures. J Bone Miner Res 2000; 15: 993-1000
3. Israel E, Banerjee TR, Fitzmaurice GM, Kotlov TV, LaHive K, LeBoff MS. Effects of inhaled glucocorticoids on bone density in premenopausal women. N Engl J Med 2001; 345: 941-947
4. Grotz WH, Mundinger FA, Rasenack J et al. Bone loss after kidney transplantation: a longitudinal study in 115 graft recipients. Nephrol Dial Transplant 1995; 10: 2096-2100
5. Gudbjornsson B, Juliusson UI, Gudjonsson FV. Prevalence of long term steroid treatment and the frequency of decision making to prevent steroid induced osteoporosis in daily clinical practice. Ann Rheum Dis 2002; 61: 32-36
6. American College of Rheumatology Task Force on Osteoporosis Guidelines. Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis. Arthritis Rheum 1996; 39: 1791-1801
7. Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis. 2001 update. American College of Rheumatology Ad Hoc Committee on Glucocoritcoid-Induced Osteoporosis. Arthritis Rheum 2001; 44: 1496-1503
8. Buckley LM, Leib ES, Cartularo KS, Vacek PM, Cooper SM. Calcium and vitamin D3 supplementation prevents bone loss in the spine secondary to low-dose corticosteroids in patients with rheumatoid arthritis. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 1996; 125: 961-968
9. Saag KG, Emkey R, Schnitzer TJ et al. Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. Glucocorticoid-Induced Osteoporosis Intervention Study Group. N Engl J Med 1998; 339: 292-299
10. Homik J, Cranney A, Shea B et al. Bisphosphonates for steroid induced osteoporosis. Cochrane Database Syst Rev 2000; 2: CD001347.
11. Dequeker J, Van Cleemput J, Declerck K, Mbuyi Muamba JM. Role of alfacalcidiol on bone quality and immunomodulation in autoimmune disease and organ transplantation. Calcif Tissue Int 1997; 60:1 28-129
12. Hamdy NA, Kanis JA, Beneton MN et al. Effect of alfacalcidol on natural course of renal bone disease in mild to moderate renal failure. Effect of alfacalcidol on natural course of renal bone disease in mild to moderate renal failure. Br Med J 1995; 310: 358-363
13. Ritz E, Kuster S, Schmidt-Gayk H et al. Low-dose calcitriol prevents the rise in 1,84-iPTH without affecting serum calcium and phosphate in patients with moderate renal failure (prospective placebo-controlled multicentre trial). Nephrol Dial Transplant 1995; 10: 2228-2234
14. Ringe JD, Coster A, Meng T, Schacht E, Umbach R. Treatment of glucocorticoid-induced osteoporosis with alfacalcidol/calcium versus vitamin D/calcium. Calcif Tissue Int 1999; 65: 337-340
15. Reginster JY, Kuntz D, Verdickt W et al. Prophylactic use of alfacalcidol in corticosteroid-induced osteoporosis. Osteoporos Int 1999; 9: 75-81
16. Roux C, Oriente P, Laan R et al. Randomized trial of effect of cyclical etidronate in the prevention of corticosteroid-induced bone loss. Ciblos Study Group. J Clin Endocrinol Metab 1998; 83: 1128-1133
17. Adachi JD, Bensen WG, Brown J et al. Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis. N Engl J Med 1997; 337: 382-387
18. Giannini S, D'Angelo A, Carraro G et al. Persistently increased bone turnover and low bone density in long-term survivors of kidney transplantation. Clin Nephrol 2001; 56: 353-363
19. Fan SL, Almond MK, Ball E, Evans K, Cunningham J. Pamidronate therapy as prevention of bone loss following renal transplantation. Kidney Int 2000; 57: 684-690
20. Henderson K, Eisman J, Keogh A et al. Protective effect of short-term calcitriol or cyclical etidronate on bone loss after cardiac or lung transplantation. J Bone Miner Res 2001; 16: 565-671
21. Amin S, LaValley MP, Simms RW, Felson DT. The role of vitamin D in corticosteroid-induced osteoporosis: a metaanalytic approach. Arthritis Rheum 1999; 42: 1740-1751
22. Felson DT, Zhang Y, Hannan MT, Kiel DP, Wilson PW, Anderson JJ. The effect of postmenopausal estrogen therapy on bone density in elderly women. N Engl J Med 1993; 329: 1141-1146
23. Buckley LM, Marquez M, Feezor R, Ruffin DM, Benson LL. Prevention of corticosteroid-induced osteoporosis: results of a patient survey. Arthritis Rheum 1999; 42: 1736-1739